US$ 23.42
safety of glp-1 receptor agonists Efficacy and LY3298176, a novel dual GIP and agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial Adverse Effects of GLP-1 Receptor
Description
A recent report covered that tirzepatide increased adiponectin levels and significantly decreased Nash related biomarkers, which was beneficial to improve NAFLD (197)

Incorporating a mix of aerobic exercises (like walking, running, or cycling) and strength training can help achieve long-term weight management goals naturally, whilst keeping your body functioning efficiently

Dulaglutide (Trulicity): Primarily used to manage blood sugar levels in type 2 diabetes, dulaglutide also offers potential benefits for weight management

Articles were reviewed for efficacy at reducing A1c (Tables 1 and 2) or for other clinical effects including effect on weight, blood pressure (BP), or other drug-related outcomes

10.1136/gut.46.5.622 108 SchirraJ.NicolausM.RoggelR.KatschinskiM.StorrM.WoerleH

It is also reasonable to assume this risk is greater the deeper the depth of sedation when the patients protective reflexes that prevent aspiration are less intact